[go: up one dir, main page]

PT2970120T - Novos compostos de pirimidina e piridina e seu uso - Google Patents

Novos compostos de pirimidina e piridina e seu uso

Info

Publication number
PT2970120T
PT2970120T PT14764299T PT14764299T PT2970120T PT 2970120 T PT2970120 T PT 2970120T PT 14764299 T PT14764299 T PT 14764299T PT 14764299 T PT14764299 T PT 14764299T PT 2970120 T PT2970120 T PT 2970120T
Authority
PT
Portugal
Prior art keywords
usage
pyridine compounds
novel pyrimidine
pyrimidine
novel
Prior art date
Application number
PT14764299T
Other languages
English (en)
Inventor
Su Wei-Guo
Zhang Weihan
Li Jinshui
Original Assignee
Hutchison Medipharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchison Medipharma Ltd filed Critical Hutchison Medipharma Ltd
Publication of PT2970120T publication Critical patent/PT2970120T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT14764299T 2013-03-15 2014-03-14 Novos compostos de pirimidina e piridina e seu uso PT2970120T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/072690 WO2014139145A1 (en) 2013-03-15 2013-03-15 Novel pyrimidine and pyridine compounds and usage thereof

Publications (1)

Publication Number Publication Date
PT2970120T true PT2970120T (pt) 2018-11-27

Family

ID=51535826

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14764299T PT2970120T (pt) 2013-03-15 2014-03-14 Novos compostos de pirimidina e piridina e seu uso

Country Status (32)

Country Link
US (2) US20160052926A1 (pt)
EP (1) EP2970120B1 (pt)
JP (1) JP6109969B2 (pt)
KR (1) KR101697982B1 (pt)
CN (1) CN105143185B (pt)
AR (1) AR095430A1 (pt)
AU (1) AU2014231437B2 (pt)
BR (1) BR112015020772B1 (pt)
CA (1) CA2900748C (pt)
CL (1) CL2015002520A1 (pt)
CY (1) CY1121804T1 (pt)
DK (1) DK2970120T3 (pt)
EA (1) EA028654B1 (pt)
ES (1) ES2697697T3 (pt)
HR (1) HRP20181906T1 (pt)
IL (1) IL240790B (pt)
LT (1) LT2970120T (pt)
MX (1) MX363397B (pt)
MY (1) MY192641A (pt)
NZ (1) NZ711460A (pt)
PE (1) PE20151601A1 (pt)
PH (1) PH12015502047B1 (pt)
PL (1) PL2970120T3 (pt)
PT (1) PT2970120T (pt)
RS (1) RS58136B1 (pt)
SG (1) SG11201506280SA (pt)
SI (1) SI2970120T1 (pt)
SM (1) SMT201800596T1 (pt)
TW (1) TWI618698B (pt)
UA (1) UA113470C2 (pt)
WO (2) WO2014139145A1 (pt)
ZA (1) ZA201505999B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN03235A (pt) 2012-11-07 2015-10-02 Karus Therapeutics Ltd
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
ME03780B (me) 2013-01-15 2021-04-20 Incyte Holdings Corp Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze
PT2994465T (pt) 2013-05-10 2018-10-25 Karus Therapeutics Ltd Novos inibidores de histona desacetilase
EA201690458A1 (ru) 2013-08-23 2016-07-29 Инсайт Корпорейшн Фуро- и тиенопиридинкарбоксамиды, используемые в качестве ингибиторов pim-киназы
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
AR105967A1 (es) 2015-09-09 2017-11-29 Incyte Corp Sales de un inhibidor de pim quinasa
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
WO2018072707A1 (zh) * 2016-10-18 2018-04-26 保诺科技(北京)有限公司 芳香族醚类衍生物、其制备方法及其在医药上的应用
MX389403B (es) * 2016-11-17 2025-03-20 Guangdong Zhongsheng Pharmaceutical Co Ltd Inhibidor del receptor del factor de crecimiento de fibroblastos 4 (fgfr4) y metodo de preparacion y uso del mismo
CN108503593B (zh) * 2017-02-28 2021-04-27 暨南大学 2-氨基嘧啶类化合物及其应用
CN108570032B (zh) * 2017-03-09 2021-04-02 华东理工大学 新型罗丹明染料及其在抗致病菌中的应用
CN107382836A (zh) * 2017-08-04 2017-11-24 吴赣药业(苏州)有限公司 一种1‑(4‑氨基苯基)‑1h‑吡啶‑2‑酮的制备方法
WO2019113487A1 (en) 2017-12-08 2019-06-13 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
AU2020367905A1 (en) * 2019-10-14 2022-04-21 Hutchison Medipharma Limited The salts of a compound and the crystalline forms thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516561A (ja) * 2003-01-17 2006-07-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 細胞増殖の阻害剤としての2−アミノピリジン置換ヘテロ環類
WO2005002673A1 (en) * 2003-07-03 2005-01-13 Astex Therapeutics Limited Raf kinase inhibitors
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
AU2006227628A1 (en) * 2005-03-16 2006-09-28 Targegen, Inc. Pyrimidine compounds and methods of use
WO2007056023A2 (en) * 2005-11-02 2007-05-18 Targegen, Inc. Thiazole inhibitors targeting resistant kinase mutations
US8030487B2 (en) * 2006-07-07 2011-10-04 Targegen, Inc. 2-amino—5-substituted pyrimidine inhibitors
CN101600714B (zh) * 2006-11-10 2013-08-21 百时美施贵宝公司 吡咯并吡啶激酶抑制剂
EP2022785A1 (en) * 2007-06-20 2009-02-11 Bayer Schering Pharma Aktiengesellschaft Alkynylpyrimidines as Tie2 kinase inhibitors
MX2010014234A (es) * 2008-06-19 2011-03-25 Astrazeneca Ab Compuestos pirazol 436.
MX2011007864A (es) * 2009-01-28 2011-09-30 Karus Therapeutics Ltd Isosteros para realzar la transcripcion y su uso en terapia.
PT2821402T (pt) * 2012-02-28 2019-10-02 Kotobuki Pharmaceutical Co Ltd Composto aromático heterocíclico que contém nitrogénio
MX365214B (es) 2012-03-08 2019-05-27 Astellas Pharma Inc Nuevo producto de fusion de fgfr3.

Also Published As

Publication number Publication date
JP2016510774A (ja) 2016-04-11
US9701680B2 (en) 2017-07-11
CA2900748A1 (en) 2014-09-18
RS58136B1 (sr) 2019-02-28
EP2970120B1 (en) 2018-09-12
CA2900748C (en) 2017-10-17
PL2970120T3 (pl) 2019-03-29
LT2970120T (lt) 2019-01-10
KR20150126391A (ko) 2015-11-11
PE20151601A1 (es) 2015-11-02
WO2014139465A1 (en) 2014-09-18
EA201591301A1 (ru) 2016-03-31
MX363397B (es) 2019-03-21
UA113470C2 (xx) 2017-01-25
DK2970120T3 (en) 2018-12-10
HK1212687A1 (zh) 2016-06-17
PH12015502047A1 (en) 2016-01-18
US20160024021A1 (en) 2016-01-28
CN105143185A (zh) 2015-12-09
HRP20181906T1 (hr) 2019-02-22
MX2015012363A (es) 2016-02-03
ES2697697T3 (es) 2019-01-25
CL2015002520A1 (es) 2016-03-28
CY1121804T1 (el) 2020-07-31
TW201439064A (zh) 2014-10-16
MY192641A (en) 2022-08-29
BR112015020772A2 (pt) 2017-07-18
AR095430A1 (es) 2015-10-14
IL240790B (en) 2019-10-31
TWI618698B (zh) 2018-03-21
SMT201800596T1 (it) 2019-01-11
AU2014231437A1 (en) 2015-09-03
KR101697982B1 (ko) 2017-01-19
EP2970120A1 (en) 2016-01-20
JP6109969B2 (ja) 2017-04-05
BR112015020772B1 (pt) 2022-06-07
SG11201506280SA (en) 2015-09-29
IL240790A0 (en) 2015-10-29
NZ711460A (en) 2019-05-31
WO2014139145A1 (en) 2014-09-18
EP2970120A4 (en) 2016-08-31
US20160052926A1 (en) 2016-02-25
PH12015502047B1 (en) 2019-03-08
AU2014231437B2 (en) 2016-11-17
CN105143185B (zh) 2018-02-13
SI2970120T1 (sl) 2019-02-28
EA028654B1 (ru) 2017-12-29
ZA201505999B (en) 2017-11-29

Similar Documents

Publication Publication Date Title
ZA201505999B (en) Novel pyrimidine and pyridine compounds and their usage
IL244373B (en) Pyrimidines inhibit fgfr4
GB201303109D0 (en) Novel pyrimidine compounds
IL240788B (en) Heterocyclic compounds and their uses
IL240804B (en) Converted pyridine and pyrazine compounds as 4pde inhibitors
IL240496A0 (en) New derivatives of pyridine
IL244817B (en) Transmuted pyrimidine compounds and their use as syk inhibitors
GB201309180D0 (en) Compounds and Their Uses
GB201314610D0 (en) Compounds and their uses
GB201306248D0 (en) Compounds and their uses
GB201313605D0 (en) Novel compounds and their use
GB201320161D0 (en) Compounds and their uses